Enjoy complimentary customisation on priority with our Enterprise License!
The gastric cancer drugs market size is forecast to increase by USD 19.49 billion, at a CAGR of 18.52% between 2023 and 2028. The market is experiencing significant growth due to several key trends. One of the primary factors driving market growth is the increasing awareness campaigns for gastric cancer, which are leading to earlier diagnoses and subsequent treatment. Additionally, the number of drug approvals and launches in the market is on the rise, providing healthcare professionals with more options to treat this deadly disease. However, the high treatment costs of gastric cancer pose a significant challenge to the market, limiting access for many patients. Despite this, advancements in research and development are expected to bring forth more cost-effective treatments, ensuring continued market growth.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Route of Administration
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.